Please login to the form below

Not currently logged in
Email:
Password:

Q&A

This page shows the latest Q&A news and features for those working in and with pharma, biotech and healthcare.

Q&A: Niels Lund

Q&A: Niels Lund

Having had a career in international development, I recognise some of his characters. ... What’s your golden rule/piece of advice for someone starting a career in health advocacy?

Latest news

  • Pharma Careers Q&A: Caroline Benson Pharma Careers Q&A: Caroline Benson

    The materials we produce based on these insights mean you can make a difference to people’s lives and this really matters to me. ... She was a nurse and got me into working as a healthcare assistant to fund my degree and PhD.

  • Q&A: Nicola Walsby Q&A: Nicola Walsby

    What’s your favourite bar or eatery? For a special occasion, Hedone in Chiswick is unbelievably good. ... What’s your golden rule/piece of advice for someone starting a career in healthcare comms?

  • Q&A: Pernille Laerkegaard Hansen Q&A: Pernille Laerkegaard Hansen

    It is a fine balance as I also really enjoy the speed in pharma. ... What’s your favourite bar or eatery? In Gothenburg, there’s a fantastic restaurant called SOMM.

  • Q&A: Beth Whitworth Q&A: Beth Whitworth

    What gets you out of bed in the morning? Having a job with purpose. ... Ask questions and don’t become a ‘yes man’. And finally, don’t stop reading.

  • Q&A: Kate Pain Q&A: Kate Pain

    My daughter. She is a ray of sunshine and makes me laugh every day. ... Challenge yourself to be a change agent and try not to fear failure.

More from news
Approximately 33 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Rare disease trials Q&A Rare disease trials Q&A

    With 350 million people affected worldwide, rare diseases represent a major unmet medical need. ... The selection of appropriate endpoints is crucial to provide substantial evidence of the efficacy of a drug.

  • The Orkambi row explained The Orkambi row explained

    Q&A and timeline. The Orkambi row still isn’t resolved. Who is to blame for this mess? ... accept such a public offer without exposing its price negotiations elsewhere in the world.

  • Immunotherapy combination trials Q&A Immunotherapy combination trials Q&A

    What factors should sponsors weigh up when planning a new IO trial in 2019 and beyond? ... as the enthusiasm and available resources to dedicate to a study, should be selected.

  • Meetings Meetings

    Is a Q&A session appropriate and is there adequate time allocated? ... If attendance is good, it helps to have a good idea of delegate profiles.

  • Brexit implications for UK pharma legislation Brexit implications for UK pharma legislation

    The EMA and Commission have already issued a Q&A document on ‘certain legal consequences that need to be considered in a timely manner’. ... is a former policy manager at the ABPI and currently works at the House of Commons.

More from intelligence
Approximately 15 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Playing Mind Games
To give a brief strong direction, we need to ascertain how the brand intends to win attention, how it will engage, what its call to action will be and how...
PM Society Digital Award Finalists
P&P are shortlisted for the ‘Craft in Film’ category at this year’s PM Society Digital Awards...
The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....

Infographics